HiSiaddi is an innovative foreign trade service provider driven by dual pillars of technology commercialization and cross-border trading. We have established a "1+2+3+4=1" service system and can supply succinic acid sourced directly from well-known original manufacturers. With over a decade of market experience and technological cooperation with manufacturers, HiSiaddi possesses extensive expertise in product compliance matters. Below is our case of resolving compliance challenges for succinic acid export.
Contact HiSiaddi customer service for further inquiries on succinic acid product compliance issues.
The buyer is PharmaCare GmbH based in Hamburg, Germany, a leading domestic German enterprise specializing in mid-to-high-end prescription formulations and infant medical nutrient solutions. Its products supply pharmacy chains across Germany and medical institutions throughout the EU. Raw material access complies with EP Pharmacopoeia, EU REACH, CLP labeling regulations, EFSA food additive E363 certification, EXCiPACT pharmaceutical excipient GMP, LFGB and full ICH impurity specifications. The enterprise planned annual procurement of 225 tons of pharmaceutical-grade bio-based succinic acid for two product lines: oral sustained-release pharmaceuticals and infant formula buffering nutrient solutions, representing a high-standard premium pharmaceutical raw material buyer. The enterprise previously sourced local European succinic acid, yet shifted to domestic Chinese raw materials amid price hikes and tight supply of European chemical products.
The client independently contracted two domestic succinic acid manufacturers and finalized a 65-ton initial batch of pharmaceutical-grade succinic acid. Prior to shipment, four critical compliance bottlenecks emerged, imposing severe risks of failed export customs clearance and cargo seizure or destruction upon arrival at Hamburg Port:
1. REACH compliance gaps: The supplying manufacturers only held domestic production qualifications, lacking formal REACH registration dossiers for succinic acid and EU Only Representative (OR) filing documents. The planned annual supply of 65 tons far exceeded the 1-ton REACH registration threshold. Absence of an ECHA registration number prohibits entry into Germany under EU regulations, resulting in cargo detention, return or on-site destruction upon arrival.
2. Non-compliant SDS & CLP labels: Manufacturers provided simplified Chinese MSDS failing the latest EU GHS+CLP regulation standards requiring full 16-section English SDS. Outer packaging retained standard domestic markings without mandatory GHS hazard pictograms, precautionary statements, CAS No. 110-15-6, UN numbers and graded hazard warnings. German customs would refuse customs clearance and warehousing under CLP regulations.
3. Missing pharmaceutical qualification documentation: For infant formula nutrient solutions, the client required EFSA-E363 additive certification, LFGB German food contact certification, full English EP Pharmacopoeia COA and factory EXCiPACT-GMP audit materials. However, manufacturers could only provide national standard quality inspection reports, lacking CNAS third-party English full-item test reports and EU pharmaceutical authority recognized compliance certificates. Even with successful customs clearance, raw materials would fail the client’s factory incoming QA qualification audit and could not be deployed to production.
4. Non-compliant domestic export customs declaration & shipping identification: Manufacturers declared goods as general cargo, while succinic acid is classified as Class 8 corrosive subsidiary hazardous chemicals under IMDG maritime transport rules. Absence of official Maritime Transport Condition Identification Reports and dangerous goods packaging performance certificates blocked normal customs declaration and booking, with shipping lines refusing cargo loading.
The German procurement team faced only 28 days until raw material production launch, with fixed new drug launch schedules. Alternative manufacturer sourcing would require a minimum 60-day lead time, and delayed new drug launches would incur millions of euros in economic losses. Introduced by multiple industry partners, the client fully entrusted HiSiaddi Foreign Trade with full-chain compliance rectification, certificate supplementary processing, customs clearance and shipment delivery services.
Drawing on years of practical experience in organic acid export compliance, HiSiaddi formed a special task force consisting of regulatory specialists, third-party testing liaisons, customs/logistics coordinators and EU compliance agents. We closed all compliance loopholes in four major segments, implementing rectifications aligned with dual standards of German pharmaceutical authorities and Chinese export customs:
1. HiSiaddi coordinated EU local compliance institutions and official EU Only Representatives (OR) to retrieve existing REACH registration dossiers for succinic acid. Based on product composition and process parameters of manufacturers, we completed tonnage roll-over registration filings matching the 225-ton annual framework order, supplemented supplementary REACH registration documents corresponding to the annual export tonnage, ECHA filing receipts and OR authorization statements. Documents clearly specified succinic acid CAS No. 110-15-6, annual export tonnage and downstream pharmaceutical application scenarios to satisfy REACH inspection requirements of German customs.
2. Simultaneously conduct SVHC Substances of Very High Concern special testing, with single SVHC substance content in all batches below the 0.1% control threshold. SVHC screening reports were appended to REACH dossiers to mitigate EU penalties for SVHC notification violations.
1. Compliance engineers recompiled full 16-section complete English SDS Safety Data Sheets per the 2025 EU GHS/CLP regulation, fully elaborating physical and chemical parameters, toxicological data, ecological data, REACH entries, storage & transportation requirements and waste disposal protocols, abolishing the original simplified Chinese MSDS.
2. Uniform revision of outer packaging labels: Outer bags printed GHS corrosion hazard pictograms, UN3265 hazard ID, PG3 packaging group, CAS number, Chinese & English product names, hazard statement H318 and precautionary statements P280/P338. All labels were pre-audited and confirmed compliant by the German importer prior to packaging and stock preparation.
1. HiSiaddi coordinated CNAS and EU-accredited third-party testing laboratories to sample bulk in-stock succinic acid for full-item testing against EP Pharmacopoeia, EFSA E363 and LFGB standards, strictly controlling key indicators including fumaric acid/maleic acid by-products, heavy metals and residual solvents. Bilingual Chinese-English COA quality inspection reports were issued.
2. Assist manufacturers in sorting production line documentation and clean workshop records, coordinate EXCiPACT institutions to organize simplified auxiliary GMP filing materials, and issue Certificates of Free Sale, bio-based raw material traceability reports and infant product safety assessment reports. The complete document package supports QA incoming qualification filing audits at German pharmaceutical factories.
1. Entrust authoritative domestic chemical identification institutions to issue official Maritime Transport Condition Identification Reports for the 65-ton batch of pharmaceutical succinic acid, clarifying hazard classification and packaging categories.
2. Upgrade original factory packaging to PE inner liners + compliant food-grade woven bags, apply for Exit Goods Packaging Performance Inspection Certificates. HiSiaddi collaborated with customs brokers to correct HS Code to 2917190090, revise declaration elements for compliant chemical commodity customs filing, and coordinate shipping lines to supplement hazardous cargo booking records to resolve cargo acceptance rejections.
1. Domestic customs release: After full supplementary compliance documentation, goods successfully completed domestic customs declaration and release, loading vessels on schedule for Hamburg Port.
2. German customs inspection: Upon cargo arrival, German customs verified REACH dossiers, CLP labels, English SDS and shipping identification documents item by item. Flawless full documentation enabled zero-delay customs clearance without fines within 3 working days for cargo pickup.
3. Factory incoming inspection: Complete EP test reports, LFGB, E363 and GMP supporting documentation passed full QA department audits at the German pharmaceutical factory. Raw materials were approved for warehousing and successfully deployed to mass production of infant nutrient solutions and sustained-release tablets, enabling scheduled launch of the client’s new drugs.
Following successful delivery of the initial 65-ton batch, the remaining 160 tons of the annual framework order were split into six staggered production batches. HiSiaddi implemented pre-shipment compliance pre-review for every batch, supporting synchronous matching of full compliance documentation prior to delivery, resulting in zero compliance issues across customs clearance and factory incoming inspection for all annual shipments.
1. The one-stop compliance rectification service from HiSiaddi closed all compliance gaps within 22 days, safeguarding the new drug production launch timeline and avoiding massive economic losses from delayed new drug market entry.
2. A complete set of archived compliance documentation enabled the enterprise to establish succinic acid supplier entry compliance standards, cutting compliance audit cycles by 60% for future procurement projects of European subsidiaries. Procurement costs of domestic succinic acid decreased by 28.6% compared with local European raw materials, optimizing global supply chain structures.
1. Guided by HiSiaddi, the factory supplemented full EU compliance certifications and perfected REACH, third-party pharmacopoeia testing and GMP compliance systems, successfully opening up the high-end German pharmaceutical market via this benchmark order. Subsequent designated procurement invitations arrived from pharmaceutical enterprises in Austria and Belgium, expanding export channels for high-end EU pharmaceutical raw materials.
2. Improved internal compliance control processes for product exports, eliminating repeated document rectification costs and compliance risks for future independent EU export orders.
1. Integrated service covering regulatory analysis, document rectification, third-party testing coordination and dual-market customs clearance established specialized compliance service advantages for fine organic acid exports to the EU, enabling deep long-term cooperation with leading German pharmaceutical enterprises beyond basic commodity trading.
2. Established a full-spectrum compliance document database for succinic acid EU exports, supporting subsequent delivery of compliance-matched procurement projects for three high-end nutritional enterprises in France and Spain, continuously expanding the pool of mid-to-high-end European pharmaceutical clients.
Most domestic succinic acid manufacturers focus on the domestic market and master national standard production protocols, yet generally lack knowledge of overseas access regulations including EU REACH, CLP, EP Pharmacopoeia and LFGB. They can only provide conventional domestic qualification documents, failing to meet stringent compliance requirements of mid-to-high-end European and American pharmaceutical clients. Overseas pharmaceutical purchasers lack familiarity with domestic Chinese export customs declaration and hazardous goods identification regulations, frequently facing critical risks of cargo non-shipment due to compliance bottlenecks after production completion. As an independent foreign trade service provider, HiSiaddi bridges regulatory gaps between domestic export supervision rules and pharmaceutical/chemical regulations of multiple EU countries, delivering one-stop resolution of cross-border dual-market compliance blind spots. We support domestic succinic acid in smooth entry into Europe’s high-end pharmaceutical track while protecting overseas high-end purchasers from compliance losses including cargo detention, destruction and production shutdowns, acting as a critical compliance hub for domestic fine chemical raw materials targeting high-end overseas markets.
Contact HiSiaddi customer service for further inquiries on succinic acid product compliance issues.
+86-13120989737 
info@hisiaddi.com 
English
